S

AN FRANCISCO — At the J.P. Morgan Healthcare Conference, as in life, scheduling is everything.

Several hundred biopharma companies scored an invitation to give a corporate presentation during this week’s industry confab — but they won’t all have an equal chance to win over investors. Some will be presenting in more glamorous rooms, with more room to fit more investors, on a day more likely to draw an energized crowd.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

X